Shares of HIMS experienced a dramatic slump today following the unexpected termination of its deal with pharmaceutical giant Novo Nordisk. Investors responded negatively to the news, sending the company's stock price plummeting by more than fifteen percent. The reason for the breakdown of the partnership remains unclear, but industry analysts specu